M05BX05 burosumab
ATC group of level 5 – chemical substance · in plain English: medicines for osteoporosis and other bone diseases
This site has the patient leaflet or the SPC of 4 medicines in this group.
- 1 prescription only (POM)
Active substance: Burosumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- M Musculo-skeletal system drugs 701 medicines
- M05 Drugs for treatment of bone diseases 135 medicines
- M05B Drugs affecting bone structure and mineralization 135 medicines
- M05BX Other drugs affecting bone structure and mineralization 36 medicines
- M05BX05 burosumab 4 medicines
- M05BX Other drugs affecting bone structure and mineralization 36 medicines
- M05B Drugs affecting bone structure and mineralization 135 medicines
- M05 Drugs for treatment of bone diseases 135 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Crysvita 10 mg solution for injection SPC | – |
| Crysvita 20 mg solution for injection SPC | – |
| Crysvita 20 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Crysvita 30 mg solution for injection SPC | – |
Other groups of the same level
- M05BX03 strontium ranelate 3 medicines
- M05BX04 denosumab 26 medicines
- M05BX06 romosozumab 2 medicines
Other names of the ATC group
- Czech: M05BX05 Burozumab
- German: M05BX05 Burosumab
- Spanish: M05BX05 BUROSUMAB
- German: M05BX05 Burosumab
- Italian: M05BX05 BUROSUMAB
- Polish: M05BX05 BUROZUMAB
- Turkish: M05BX05 burosumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group M05BX05
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.